Series date: 
01/01/2024 - 7:00am CST to 12/31/2024 - 8:00am CST

Course Director:
Ajay Sahajpal, MD
Overall Objectives:

  1. Summarize and evaluate multidisciplinary recommended “best practice” treatment options for patients with liver tumors and liver cancers.
  2. Identify normal and abnormal liver findings.
  3. Develop treatment strategies for abnormal liver finding which may be applied to current and future cases in their practice.

Target Audience:
Hepatologist, Hepatobiliary surgeons, Radiologist, Oncologist, Physician Assistants, Nurse Practitioners, and Nurse Coordinators

Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement
American Medical Association (AMA) 

Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Board Recognition Statement(s)
American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Series location: 
Aurora St. Luke's Medical Center
2900 W Oklahoma Avenue
Galleria Building, 5th Floor Conference Room and Virtual
Milwaukee, WI 53215
United States